James G. Marken
Net Worth

Last updated:

What is James G. Marken net worth?

The estimated net worth of Mr. James G. Marken is at least $24,153,861 as of 7 Jun 2024. He owns shares worth $11,191,818 as insider, has earned $5,090,223 from insider trading and has received compensation worth at least $7,871,820 in ANI Pharmaceuticals, Inc..

What is the salary of James G. Marken?

Mr. James G. Marken salary is $715,620 per year as Senior Vice President of Operations & Product Devel. in ANI Pharmaceuticals, Inc..

How old is James G. Marken?

Mr. James G. Marken is 62 years old, born in 1963.

What stocks does James G. Marken currently own?

As insider, Mr. James G. Marken owns shares in one company:

Company Title Shares Price per share Total value
ANI Pharmaceuticals, Inc. (ANIP) Senior Vice President of Operations & Product Devel. 124,492 $89.9 $11,191,818

What does ANI Pharmaceuticals, Inc. do?

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANIP logo
ANIP
ANI Pharmaceuticals, Inc.
$89.9

James G. Marken insider trading

ANI Pharmaceuticals, Inc.

Mr. James G. Marken has made 10 insider trades between 2014-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 24,338 units of ANIP stock on 7 Mar 2024. As of 7 Jun 2024 he still owns at least 124,492 units of ANIP stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 7,250 $49.51 $358,948
Option
Stock Option (right to buy) 12,550 $53.29 $668,727
Option
Common Stock 5,300 $57.06 $302,418
Sale
Common Stock 24,338 $66.37 $1,615,313
Sale
Common Stock 3,932 $63 $247,716
Option
Common Stock 3,750 $40.59 $152,213
Option
Common Stock 1,667 $33 $55,011
Option
Stock Option (right to buy) 5,417 $36.8 $199,319
Sale
Common Stock 5,172 $37.79 $195,465
Sale
Common Stock 12,894 $37.04 $477,607
Sale
Common Stock 8,907 $70.67 $629,458
Sale
Common Stock 4,917 $70.31 $345,714
Option
Common Stock 18,001 $19.68 $354,260
Option
Stock Options 18,001 $19.68 $354,260
Sale
Common Stock 4,177 $61.92 $258,640
Sale
Common Stock 3,500 $43.26 $151,410
Option
Option to Purchase Common Stock 7,395 $6.36 $47,032
Option
Common Stock 7,395 $6.36 $47,032
Option
Option to Purchase 9,020 $19.68 $177,514
Option
Common Stock 9,020 $19.68 $177,514
Sale
Common Stock 15,000 $66.5 $997,500
Sale
Common Stock 5,000 $34.28 $171,400

ANI Pharmaceuticals key executives

ANI Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: